Company profilePharmaceutical#239 of 1,318 in Pakistan✓ No DRAP alerts

MIRACLE PHARMACEUTICALS(PVT) LTD

Pharmaceutical company · 77 brands · 73 molecules

Ranked #99 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

77 registered products 27 pharmaceutical brands 73 distinct molecules 0 DRAP alerts

Company overview

77
registered products
27
pharmaceutical brands
73
distinct molecules
12
therapeutic classes
0
DRAP alerts

MIRACLE PHARMACEUTICALS(PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 77 product registrations across 73 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antiemetics & Antinauseants. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 4Antiemetics & Antinauseants · 2Lipid Modifying Agents · 2Antianemic, Iron Preparations · 2Angiotensin-Ii Antagonists, Combinations · 2Vitamin B12 Plain · 1Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 1Macrolides, Lincosamides And Streptogramins · 1Antianemic, Iron & All Combination · 1Antispasmodic & Anticholinergic · 1Agents Against Amoebiasis And Other Protozoal Diseases · 1Quinolone Antibacterials · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official1 products · Rs 267.78 – Rs 267.78
Median across source: Rs 267.78

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for MIRACLE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.